The effects of excitotoxic lesion of the medial prefrontal cortex on latent inhibition, prepulse inhibition, food hoarding, elevated plus maze, active avoidance and locomotor activity in the rat

Neuroscience

Volumn 84, Issue 2, 1998, Pages 431-442

  Lacroix, L ^a   Broersen, L M ^b   Weiner, I ^c   Feldon, J ^a  

^a Institute of Toxicology Schwerzenbach   (Switzerland)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Hoarding; Latent inhibition; NMDA; Prefrontal cortex; Rat; Schizophrenia

Indexed keywords

AMPHETAMINE; DOPAMINE; N METHYL DEXTRO ASPARTIC ACID; WATER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AVOIDANCE BEHAVIOR; CONTROLLED STUDY; HIPPOCAMPUS; LATENT INHIBITION; LOCOMOTION; MALE; MAZE TEST; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT;

ACOUSTIC STIMULATION; ANIMALS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; BRAIN MAPPING; CONDITIONING, CLASSICAL; DEXTROAMPHETAMINE; FEEDING BEHAVIOR; INHIBITION (PSYCHOLOGY); MALE; MAZE LEARNING; MOTOR ACTIVITY; N-METHYLASPARTATE; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; RATS; RATS, WISTAR; STARTLE REACTION;

EID: 0031890523     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(97)00521-6     Document Type: Article

References (102)

1. Ackil J., Mellgren R. L., Halgren C., Frommer S. P. Effects of CS preexposure on avoidance learning in rats with hippocampal lesions. J. comp. physiol. Psychol. 69:1969;739-747.
2. Andreasen N. C., Rezai K., Alliger R., Swayze V. W., Flaum M., Kirchner P., Cohen G., Oleary D. S. Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia-assessment with xenon-133 single-photon emission computed tomography and the Tower of London. Archs gen. Psychiat. 49:1992;943-958.
3. Baruch I., Hemsley D., Gray J. A. Differential performance of acute and chronic schizophrenics in a latent inhibition task. J. nerv. ment. Dis. 176:1988;598-606.
4. Baruch I., Hemsley D. R., Gray J. A. Latent inhibition and "psychotic proneness" in normal subjects. Pers. on Indiv. Differ. 9:1988;777-783.
5. Bogerts B. Recent advances in the neuropathology of schizophrenia. Schizophr. Bull. 19:1993;431-445.
6. Bogerts B., Meertz E., Schonfeld-Bausch R. Basal ganglia and limbic system pathology in schizophrenia. Archs gen. Psychiat. 42:1985;784-791.
7. Braun A. R., Jaskiw G. E., Vladar K., Sexton R. H., Kolachana B. S., Weinberger D. R. Effects of ibotenic acid lesion of the medial prefrontal cortex on dopamine agonist-related behaviors in the rat. Pharmac. Biochem. Behav. 46:1993;51-60.
8. Breier A., Buchanan R. W., Elkashef A., Munson R. C., Kirkpatrick B., Gellad F. Brain morphology and schizophrenia: a magnetic resonance imaging study of limbic, prefrontal and caudate structures. Archs gen. Psychiat. 49:1992;921-926.
9. Brito G. N., Brito L. S. Septohippocampal system and the prelimbic sector of frontal cortex: a neuropsychological battery analysis in the rat. Behav. Brain Res. 36:1990;127-146.
10. Broersen L. M., Heinsbroek R. P. W., DeBruin J. P. C., Olivier B. Effects of local application of dopaminergic drugs into the medial prefrontal cortex of rats on latent inhibition. Biol. Psychiat. 40:1996;1083-1090.
11. Bubser M., Schmidt W. J. 6-Hydroxydopamine lesion of the rat prefrontal cortex increases locomotor activity, impairs acquisition of delayed alternation tasks, but does not affect uninterrupted tasks in the radial maze. Behav. Brain Res. 5:1990;157-168.
12. Burns L. H., Annett L., Kelley A. E., Everitt B. J., Robbins T. W. Effects of lesions to amygdala, ventral subiculum, medial prefrontal cortex, and nucleus accumbens on the reaction to novelty: implication for limbic-striatal interactions. Behav. Neurosci. 110:1996;60-73.
13. Burton H. A., Toga A. W. Successive discrimination performance improves with increasing number of preexposures in septal rats. Behav. neural Biol. 34:1982;141-157.
14. Callicott J. H. and Weinberger D. R. (1995) Schizophrenia and intracortical "dysconnection": new insights about pathophysiology and mechanisms of antipsychotic treatment. In Critical Issues in the Treatment of Schizophrenia (eds Brunello N., Racagni G., Langer S. Z. and Mendelewicz J.), Vol. 10, pp. 66-76. Kager, Basel.
15. Christison G. W., Atwater G. E., Dunn L. A., Kilts C. D. Haloperidol enhancement of latent inhibition: relation to therapeutic action? Biol. Psychiat. 23:1988;746-749.
16. Csernansky J. G., Murphy G. M., Faustman W. O. Limbic/mesolimbic connections and the pathogenesis of schizophrenia. Biol. Psychiat. 30:1991;383-400.
17. Dawson G. R., Tricklebank M. D. Use of the elevated plus maze in the search for novel anxiolytic agents. Trends pharmac. Sci. 16:1995;33-36.
18. De Brabander J. M., De Bruin J. P., Van Eden C. G. Comparison of the effects of neonatal and adult medial prefrontal cortex lesions on food hoarding and spatial delayed alternation. Behav. Brain Res. 42:1991;67-75.
19. Deutch A. Y., Cameron D. S. Pharmacological characterization of dopamine systems in the nucleus accumbens core and shell. Neuroscience. 46:1992;49-56.
20. Divac I., Mogenson J., Blanchard R. J., Blanchard D. C. Mesial cortical lesions and fear behavior in the wild rat. Physiol. Psychol. 12:1984;271-274.
21. Dunn L. A., Atwater G. E., Kilts C. D. Effects of antipsychotic drugs on latent inhibition - sensitivity and specificity of an animal behavioral model of clinical drug action. Psychopharmacology. 112:1993;315-323.
22. Dunn L. A., Scibilia R. J. Reaction time and pupil response measures show reduced latent inhibition in chronic schizophrenia. Soc. Neurosci., Abstr. 22:1996;239.
23. Ellenbroek B. A., Budde S., Cools A. R. Prepulse inhibition and latent inhibition: the role of dopamine in the medial prefrontal cortex. Neuroscience. 75:1996;535-542.
24. Feldon J., Shofel A., Weiner I. Latent inhibition is unaffected by direct dopamine agonists. Pharmac. Biochem. Behav. 38:1991;309-314.
25. Feldon J., Weiner I. From an animal model of an attentional deficit towards new insights into the pathophysiology of schizophrenia. J. Psychiat. Res. 26:1992;345-366.
26. Frysztak R. J., Neafsey E. J. The effect of medial frontal cortex lesions on respiration, "freezing," and ultrasonic vocalizations during conditioned emotional responses in rats. Cerebr. Cortex. 1:1991;418-425.
27. Frysztak R. J., Neafsey E. J. The effect of medial frontal cortex lesions on cardiovascular conditioned emotional responses in the rat. Brain Res. 18:1994;181-193.
28. Goldberg T. E., Weinberger D. R., Berman K. F., Pliskin N. H., Podd M. H. Further evidence for dementia of the prefrontal type in schizophrenia. A controlled study of teaching the Wisconsin Card Sorting Test. Archs gen. Psychiat. 44:1987;1008-1014.
29. Goldman-Rakic P. S. Topography of cognition: parallel distributed networks in primate association cortex. A. Rev. Neurosci. 11:1988;137-156.
30. Grace A. A. Commentary - Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience. 41:1991;1-24.
31. Gray J. A., Feldon J., Rawlins J. N. P., Hemsley D. R., Smith A. D. The neuropsychology of schizophrenia. Behav. Brain Sci. 14:1991;1-84.
32. Gray J. A., Moran P. M., Grigoryan G., Peters S. L., Young A. M. J., Joseph M. H. Latent inhibition: the nucleus accumbens connection revisited. Behav. Brain Res. 88:1997;27-34.
33. Gray N. S., Hemsley D. R., Gray J. A. Abolition of latent inhibition in acute, but not chronic, schizophrenics. Neurol. psychiat. Brain Res. 1:1992;83-89.
34. Gray N. S., Pickering A. D., Hemsley D. R., Dawling S., Gray J. A. Abolition of latent inhibition by a single 5 mg dose of D-amphetamine in man. Psychopharmacology. 107:1992;425-430.
35. Gray N. S., Pilowsky L. S., Gray J. A., Kerwin R. W. Latent inhibition in drug naive schizophrenics: relationship to duration of illness and dopamine D2 binding using SPET. Schizophr. Res. 17:1995;95-107.
36. Green S. and Hodges H. (1991) Animal models of anxiety. In Behavioral Models in Psychopharmacology: Theoretical, Industrial and Clinical Perspectives (ed. Willner P.), pp. 21-49. Cambridge University Press, Cambridge.
37. Groenewegen H. J., Wright C. I., Beijer A. V. J. The nucleus accumbens: gateway for limbic structures to reach the motor system? Prog. Brain Res. 107:1996;485-511.
38. Han J. S., Gallagher M., Holland P. Hippocampal lesions disrupt decrements but not increments in conditioned stimulus processing. J. Neurosci. 15:1995;7323-7329.
39. Holson R. R. Mesial prefrontal cortical lesions and timidity in rats. I. Reactivity to aversive stimuli. Physiol. Behav. 37:1986;221-230.
40. Holson R. R. Mesial prefrontal cortical lesions and timidity in rats. III. Behavior in a semi-natural environment. Physiol. Behav. 37:1986;239-247.
41. Holson R. R., Walker C. Mesial prefrontal cortical lesions and timidity in rats. II. Reactivity to novel stimuli. Physiol. Behav. 37:1986;231-238.
42. Jaskiw G. E., Karoum F., Freed W. J., Phillips I., Kleinman J. E., Weinberger D. R. Effect of ibotenic acid lesions of the medial prefrontal cortex on amphetamine-induced locomotion and regional brain catecholamine concentrations in the rat. Brain Res. 534:1990;263-272.
43. Jaskiw G. E., Karoum F. K., Weinberger D. R. Persistent elevations in dopamine and its metabolites in the nucleus accumbens after mild subchronic stress in rats with ibotenic acid lesions of the medial prefrontal cortex. Brain Res. 534:1990;321-323.
44. Jaskiw G. E., Weinberger D. R. Ibotenic acid lesions of medial prefrontal cortex augment swim-stress-induced locomotion. Pharmac. Biochem. Behav. 41:1992;607-609.
45. Joel D., Weiner I., Feldon J. Electrolytic lesions of the medial prefrontal cortex in rats disrupt performance on an analog of the Wisconsin Card Sorting Test, but do not disrupt latent inhibition: implications for animal models of schizophrenia. Behav. Brain Res. 85:1997;187-201.
46. Joyce J. N. The dopamine hypothesis of schizophrenia: limbic interactions with serotonin and norepinephrine. Psychopharmacology. 112(Suppl):1993;16-34.
47. Kalsbeek A., De-Bruin J. P., Feenstra M. G., Matthijssen M. A., Uylings H. B. Neonatal thermal lesions of the mesolimbocortical dopaminergic projection decrease food-hoarding behavior. Brain Res. 475:1988;80-90.
48. Kaye H., Pearce J. M. Hippocampal lesions attenuate latent inhibition of a CS and of a neutral stimulus. Psychobiology. 15:1987;293-299.
49. Kaye H., Pearce J. M. Hippocampal lesions attenuate latent inhibition and the decline of the orienting response in rats. Q. Jl exp. Psychol. 39B:1987;107-125.
50. Killcross A. S., Dickinson A., Robbins T. W. Amphetamine-induced disruptions of latent inhibition are reinforcer mediated - implications for animal models of schizophrenic attentional dysfunction. Psychopharmacology. 115:1994;185-195.
51. Killcross A. S., Dickinson A., Robbins T. W. Effects of the neuroleptic alpha-flupenthixol on latent inhibition in aversively- and appetitively-motivated paradigms - evidence for dopamine-reinforcer interactions. Psychopharmacology. 115:1994;196-205.
52. Killcross A. S., Robbins T. W. Differential effects of intra-accumbens and systemic amphetamine on latent inhibition using an on-baseline, within-subject conditioned suppression paradigm. Psychopharmacology. 110:1993;479-489.
53. King D., Zigmond M. J., Finlay J. M. Effects of dopamine depletion in the medial prefrontal cortex on the stress-induced increase in extracellular dopamine in the nucleus accumbens core and shell. Neuroscience. 77:1997;141-153.
54. Kolb B., Nonneman A. J., Singh R. K. Double dissociation of spatial impairment and perseveration following selective prefrontal lesions in rats. J. comp. physiol. Psychol. 87:1974;772-780.
55. Lipska B. K., Jaskiw G. E., Chrapusta S., Karoum F., Weinberger D. R. Ibotenic acid lesion of the ventral hippocampus differentially affects dopamine and its metabolites in the nucleus accumbens and prefrontal cortex in the rat. Brain Res. 585:1992;1-6.
56. Lubow R. E. Latent inhibition. Psychol. Bull. 79:1973;398-407.
57. Lubow R. E. (1989) Latent Inhibition and Conditioned Attention Theory. Cambridge University Press, Cambridge, England.
58. Lubow R. E., Gewirtz J. C. Latent inhibition in humans: data, theory and implications for schizophrenia. Psychol. Bull. 117:1995;87-103.
59. Maaswinkel H., Gispen W. H., Spruijt B. M. Effects of an electrolytic lesion of the prelimbic area on anxiety-related and cognitive tasks in the rat. Behav. Brain Res. 79:1996;51-59.
60. Morgan M. A., LeDoux J. E. Differential contribution of dorsal and ventral medial prefrontal cortex to the acquisition and extinction of conditioned fear in rats. Behav. Neurosci. 109:1995;681-688.
61. Morgan M. A., Romanski L. M., LeDoux J. E. Extinction of emotional learning: contribution of medial prefrontal cortex. Neurosci. Lett. 26:1993;109-113.
62. Nieoullon A., Cheramy A., Glowinski J. Release of dopamine evoked by electrical stimulation of the motor and visual areas of the cerebral cortex in both caudate and in the substantia nigra in the cat. Brain Res. 145:1978;69-83.
63. Nonneman A. J., Corwin J. W. Differential effects of prefrontal cortex ablation in neonatal, juvenile, and young adult rats. J. comp. physiol. Psychol. 95:1981;588-602.
64. Nonneman A. J., Voigt J., Kolb B. E. Comparisons of behavioral effects of hippocampal and prefrontal cortex lesions in the rat. J. comp. physiol. Psychol. 87:1974;249-260.
65. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates, 2nd edn. Academic, San Diego.
66. Peters S. L., Joseph M. H. Haloperidol potentiation of latent inhibition in rats: evidence for a critical role at conditioning rather than preexposure. Behav. Pharmac. 4:1993;183-186.
67. Pycock C. J., Kerwin R. W., Carter C. J. Effect of 6-hydroxydopamine lesions of the medial prefrontal cortex on neurotransmitter systems in subcortical sites in the rat. J. Neurochem. 34:1980;91-99.
68. Radcliffe R. A., Erwin V. G. Alterations in locomotor activity after microinjections of GBR-12909, selective dopamine antagonists or neurotensin into the medial prefrontal cortex. J. Pharmac. exp. Ther. 277:1996;1467-1476.
69. Robbins T. W. The case for frontostriatal dysfunction in schizophrenia. Schizophr. Bull. 16:1990;391-402.
70. Solomon P., Moore J. W. Latent inhibition and stimulus generalization of the classically conditioned nictitating membrane response in rabbits (Oryctolagus cuniculus) following dorsal hippocampal ablation. J. comp. physiol. Psychol. 89:1975;1192-1203.
71. Solomon P. R., Staton D. M. Differential effects of microinjections of D-amphetamine into the nucleus accumbens or the caudate putamen on the rat's ability to ignore an irrelevant stimulus. Biol. Psychiat. 17:1982;743-756.
72. Stam C. J., De-Bruin J. P., Van-Haelst A. M., Van-der-Gugten J., Kalsbeek A. Influence of the mesocortical dopaminergic system on activity, food hoarding, social-agonistic behavior, and spatial delayed alternation in male rats. Behav. Neurosci. 103:1989;24-35.
73. Swerdlow N. R., Braff D. L., Hartston H., Perry W., Geyer M. A. Latent inhibition in schizophrenia. Schizophr. Res. 20:1996;91-103.
74. Swerdlow N. R., Braff D. L., Taaid N., Geyer M. A. Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. Archs gen. Psychiat. 51:1994;139-154.
75. Swerdlow N. R., Caine S. B., Braff D. L., Geyer M. A. The neural substrates of sensorimotor gating of the startle reflex: a review of recent findings and their implications. J. Psychopharmac. 6:1992;176-190.
76. Swerdlow N. R., Filion D., Geyer M. A., Braff D. L. "Normal" personality correlates of sensorimotor, cognitive, and visuospatial gating. Biol. Psychiat. 37:1995;286-299.
77. Swerdlow N. R., Lipska B. K., Weinberger D. R., Braff D. L., Jaskiw G. E., Geyer M. A. Increased sensitivity to the sensorimotor gating-disruptive effects of apomorphine after lesions of medial prefrontal cortex or ventral hippocampus in adult rats. Psychopharmacology, Berlin. 122:1995;27-34.
78. Taber M. T., Fibiger H. C. Electrical stimulation of the media] prefrontal cortex increases dopamine release in the striatum. Neuropsychopharmacology. 9:1993;271-275.
79. Tai C. T., Cassaday H. J., Feldon J., Rawlins J. N. P. Both electrolytic and excitotoxic lesions of nucleus accumbens disrupt latent inhibition of learning in rats. Neurobiol. Learning Memory. 64:1995;36-48.
80. Tarrasch R., Weiner I., Rawlins J. N. P., Feldon J. Disruption of latent inhibition by interrupting the subicular input into the nucleus accumbens and its antagonism by haloperidol. Psychopharmac. Abstr. 6:1992;111.
81. Thompson T. L., Moss R. L. In vivo stimulated dopamine release in the nucleus accumbens: modulation by the prefrontal cortex. Brain Res. 686:1995;93-98.
82. Thornton J. C., Dawe S., Lee C., Capstick C., Corr P. J., Cotter P., Frangou S., Gray N. S., Russell M. A. H., Gray J. A. Effects of nicotine and amphetamine on latent inhibition in human subjects. Psychopharmacology. 127:1996;164-173.
83. Toga A. W., Burton H. A. Effects of the lateral septum and latent inhibition on successive discrimination learning. J. Neurosci. Res. 4:1979;215-224.
84. Vaitl D., Lipp O. V. Latent inhibition and autonomic responses: a psychophysiological approach. Behav. Brain Res. 88:1997;85-93.
85. Warburton E. C., Joseph M. H., Feldon J., Weiner I., Gray J. A. Antagonism of amphetamine-induced disruption of latent inhibition in rats by haloperdiol and ondansetron-implications for a possible antipsychotic action of ondansetron. Psychopharmacology. 114:1994;657-664.
86. Weinberger D. R. Implications of normal brain development for the pathogenesis of schizophrenia. Archs gen. Psychiat. 44:1987;660-669.
87. Weiner I. Neural substrates of latent inhibition: the switching model. Psychol. Bull. 108:1990;442-461.
88. Weiner I., Feldon J. Facilitation of latent inhibition by haloperidol. Psychopharmacology. 91:1987;248-253.
89. Weiner I., Feldon J. The switching model of latent inhibition: an update of neural substrates. Behav. Brain Res. 88:1997;11-25.
90. Weiner I., Gal G., Rawlins J. N. P., Feldon J. Differential involvement of the shell and core subterritories of the nucleus accumbens in latent inhibition and amphetamine induced activity. Behav. Brain Res. 81:1996;123-133.
91. Weiner I., Izraeli-Telerant A., Feldon J. Latent inhibition is not affected by acute or chronic administration of 6 mg/kg DL-amphetamine. Psychopharmacology. 91:1987;345-351.
92. Weiner I., Lubow R. E., Feldon J. Chronic amphetamine and latent inhibition. Behav. Brain Res. 2:1981;285-286.
93. Weiner I., Lubow R. E., Feldon J. Abolition of the expression but not the acquisition of latent inhibition by chronic amphetamine in rats. Psychopharmacology. 83:1984;194-199.
94. Weiner I., Lubow R. E., Feldon J. Disruption of latent inhibition by acute administration of low doses of amphetamine. Pharmac. Biochem. Behav. 30:1988;871-878.
95. Weiner I., Shadach E., Barkai R., Feldon J. Haloperidol and clozapine-induced enhancement of latent inhibition with extended conditioning: implications for the mechanism of action of neuroleptic drugs. Neuropsychopharmacology. 16:1997;42-50.
96. Weiner I., Shadach E., Tarrasch R., Kidron R., Feldon J. The latent inhibition model of schizophrenia: further validation using the atypical neuroleptic, clozapine. Biol. Psychiat. 40:1996;834-843.
97. Weiss K., Friedman R., McGregor S. Effects of septal lesions on latent inhibition and habituation of the orienting response in rats. Acta neurobiol experimentalis. 34:1974;419-504.
98. Whishaw I. Q., Oddie S. D. Qualitative and quantitative analyses of hoarding in medial frontal cortex rats using a new behavioral paradigm. Behav. Brain Res. 33:1989;255-266.
99. Williams J. H., Wellman N. A., Geaney D. P., Feldon J., Rawlins J. N. P., Cowen P. J. Anti-psychotic drug effects in a model of schizophrenic attentional disorder: a randomised trial of the effects of haloperidol on latent inhibition in healthy people. Biol. Psychiat. 40:1996;1135-1143.
100. Yee B. K., Feldon J., Rawlins J. N. P. Latent inhibition in rats is abolished by NMDA-induced neuronal loss in the retrohippocampal region but this lesion effect can be prevented by systemic haloperidol treatment. Behav. Neurosci. 109:1995;227-240.
101. Young A. M. J., Joseph M. H., Gray J. A. Latent inhibition of conditioned dopamine release in rat nucleus accumbens. Neuroscience. 54:1993;5-9.
102. Zahm D. S., Brog J. S. On the significance of subterritories in the "accumbens" part of the rat ventral striatum. Neuroscience. 50:1992;751-767.